After 25 years in medtech, here’s what I’ll say plainly. AI in women’s health is the biggest opportunity we’ve seen in decades, and it’s also one of the fastest ways to make existing problems worse if we get it wrong.
I’m saying that as the CEO of an FDA-cleared AI diagnostics company focused on breast imaging for women with dense tissue. I’ve been in the room building these systems, getting them through regulatory, and watching how they actually perform in the real world. The view here is grounded in what happens when the model meets the patient, not in theory.
Where AI Can Actually Move the Needle
AI has the potential to fix some of the most stubborn problems in women’s health, including delayed diagnosis, inconsistent care, manual data work, and systems that were never designed around female physiology in the first place.
Take breast imaging, my area of current focus. Nearly half of women have dense breast tissue, which makes tumors significantly harder to detect on standard mammography. Mammographic sensitivity drops sharply in dense tissue, low enough that up to half of cancers can go undetected. A miss rate at that scale points to a structural failure in how screening is designed.
AI can change that. It can surface patterns the human eye can’t see, standardize interpretation, and give clinicians better tools to make decisions faster. Our work at DeepLook Medical is in this category: technology that augments the radiologist rather than replacing them, and helps visualize what would otherwise be invisible.
It’s why organizations like the World Economic Forum are right to flag AI-driven models in women’s health as a major investment priority. Done correctly, AI can compress years of diagnostic delay into minutes, expand access in underserved areas, and start to close outcome gaps that have existed for decades.
That all hinges on getting the data, the design, and the intent right.
How Biased Data Becomes Biased AI
AI is only as good as the data it’s trained on. Healthcare data has historically underrepresented women, mischaracterized their symptoms, or ignored them entirely outside of reproductive health.
When you build AI on top of that foundation, what you get is amplified bias, faster, at scale, and with more confidence than the human-driven version it’s replacing.
Algorithms miss cardiac events in women because symptoms present differently. Imaging models underperform because training datasets skew male or don’t account for density variation. Diagnostic tools fail in diverse populations because the data didn’t include them in the first place.
This has already happened across multiple AI applications in healthcare.
The more dangerous part is that AI carries a false sense of objectivity. People assume the output is right because it’s “data-driven,” but if the data is flawed, the output is flawed.
The real risk is that AI in women’s health will work for some women and fail others, while the system tells everyone it’s working.
The Five Things Most AI Builders Skip
There’s a narrative right now that you can simply “apply AI” to women’s health and unlock value. The reality is more complicated. Building AI that performs for women requires intentional design at every step, and most companies are skipping at least one of them.
Data
You need datasets that reflect female biology across the lifespan, not a single subset of women and not a single condition. That includes differences in age, ethnicity, hormonal status, and comorbidities. If you’re not designing for that complexity, your model will break in the real world. We made sure our training and validation cohorts represented women across demographics, because anything else would have produced a tool that performed for some patients and failed others.
Clinical Context
Women’s health isn’t a single category. It cuts across oncology, cardiology, endocrinology, and mental health, all interacting. Most systems today are built in silos, which doesn’t map to how women experience health.
Workflow
If your AI tool doesn’t integrate into how clinicians actually work, the model’s quality is irrelevant. It either won’t get used, or it will get used incorrectly. We designed our technology to be device-agnostic and to fit directly into existing radiology workflows, because friction kills adoption.
Validation
You don’t get to claim success because your model performed well in a controlled dataset. You need real-world evidence across diverse populations, and that’s where most systems fall apart.
Regulatory Discipline
AI in healthcare is moving fast, and regulation is moving alongside it. If you’re not building with that in mind from day one, you’re building a product that won’t survive. After enough time navigating FDA pathways, I’ll say it directly: this isn’t optional, and it’s the difference between a demo and a deployable product.
Why So Many Healthcare AI Tools Fail
What worries me right now is how many companies are repeating the same mistakes. They’re moving fast, chasing headlines, and skipping the hard parts. We’ve seen this movie before in medtech, where overpromising leads to underdelivery, which leads to lost trust.
In women’s health, we don’t have the luxury of another cycle of that. Trust in healthcare is already fragile for women, who have been dismissed, misdiagnosed, and underrepresented for decades. If AI reinforces that experience, it sets the entire space back.
Women’s Health Is the Test Case for Healthcare AI
The bigger point sits one level up. Every company deploying AI in healthcare right now is making choices that will determine who benefits and who gets left behind. Women’s health is the most visible example of what happens when those choices skew toward speed and convenience instead of rigor.
We’re at an inflection point. The combination of increased investment, regulatory momentum, and technological capability means the next few years will define how AI shows up in healthcare for the next decade. The companies that get it right will compound advantage. The companies that don’t will produce expensive failures that take a long time to unwind.
The Bar for Building Healthcare AI Right
For anyone building or deploying AI in healthcare, the bar is simple to state and harder to meet. Interrogate the data, including who’s missing, who’s underrepresented, and what assumptions the dataset embeds. Design for real populations rather than idealized ones. Validate in the environments where the product will actually be used, not the ones where validation is easiest. Build with regulatory and clinical rigor from day one. And stay honest about what the technology can and cannot do.
Most importantly, stop treating women’s health as an edge case.
AI is already transforming women’s health. What’s still being decided is whether companies build the version that closes outcome gaps or the version that scales the bias that created them. Those choices are getting made right now.